These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23016758)

  • 61. Gram-positive bacterial resistance. A challenge for the next millennium.
    Bassetti M; Melica G; Cenderello G; Rosso R; Di Biagio A; Bassetti D
    Panminerva Med; 2002 Sep; 44(3):179-84. PubMed ID: 12094131
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Potency and antimicrobial spectrum update for piperacillin/tazobactam (2000): emphasis on its activity against resistant organism populations and generally untested species causing community-acquired respiratory tract infections.
    Johnson DM; Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2002 May; 43(1):49-60. PubMed ID: 12052629
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
    Pucci MJ; Cheng J; Podos SD; Thoma CL; Thanassi JA; Buechter DD; Mushtaq G; Vigliotti GA; Bradbury BJ; Deshpande M
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1259-67. PubMed ID: 17242152
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The need for new therapeutic agents: what is the pipeline?
    Shah PM
    Clin Microbiol Infect; 2005 May; 11 Suppl 3():36-42. PubMed ID: 15900655
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
    Doernberg SB; Lodise TP; Thaden JT; Munita JM; Cosgrove SE; Arias CA; Boucher HW; Corey GR; Lowy FD; Murray B; Miller LG; Holland TL;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S24-S29. PubMed ID: 28350900
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Patterns of isolation of common gram positive bacterial pathogens and their susceptibilities to antimicrobial agents in Jimma Hospital.
    Gebreselassie S
    Ethiop Med J; 2002 Apr; 40(2):115-27. PubMed ID: 12240573
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008).
    Bell JM; Turnidge JD; Sader HS; Jones RN
    Pathology; 2010; 42(5):470-3. PubMed ID: 20632825
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mechanisms of action of newer antibiotics for Gram-positive pathogens.
    Hancock RE
    Lancet Infect Dis; 2005 Apr; 5(4):209-18. PubMed ID: 15792738
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In Vitro and in Vivo Evaluation of Membrane-Active Flavone Amphiphiles: Semisynthetic Kaempferol-Derived Antimicrobials against Drug-Resistant Gram-Positive Bacteria.
    Lin S; Li H; Tao Y; Liu J; Yuan W; Chen Y; Liu Y; Liu S
    J Med Chem; 2020 Jun; 63(11):5797-5815. PubMed ID: 32400157
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of Gram-positive infections in critically ill patients.
    Vazquez-Guillamet C; Kollef MH
    BMC Infect Dis; 2014 Nov; 14():92. PubMed ID: 25431211
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antimicrobial Activities of Methanol, Ethanol and Supercritical CO2 Extracts of Philippine Piper betle L. on Clinical Isolates of Gram Positive and Gram Negative Bacteria with Transferable Multiple Drug Resistance.
    Valle DL; Cabrera EC; Puzon JJ; Rivera WL
    PLoS One; 2016; 11(1):e0146349. PubMed ID: 26741962
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies.
    Falagas ME; Roussos N; Gkegkes ID; Rafailidis PI; Karageorgopoulos DE
    Expert Opin Investig Drugs; 2009 Jul; 18(7):921-44. PubMed ID: 19548851
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 74. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Omadacycline Enters the Ring: A New Antimicrobial Contender.
    Barber KE; Bell AM; Wingler MJB; Wagner JL; Stover KR
    Pharmacotherapy; 2018 Dec; 38(12):1194-1204. PubMed ID: 30290000
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Linezolid: a review of its use in the management of serious gram-positive infections.
    Perry CM; Jarvis B
    Drugs; 2001; 61(4):525-51. PubMed ID: 11324682
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Nationwide sensitivity surveillance of ciprofloxacin and various parenteral antibiotics against bacteria isolated from patients with severe infections--the first Ciproxan IV special investigation in 2001].
    Yamaguchi K; Ishii Y; Iinuma Y; Yamanaka K; Ichiyama S; Watanabe N; Uehara N; Kaku M; Kurokawa Y; Hayashi M; Hirakata Y
    Jpn J Antibiot; 2003 Dec; 56(6):546-73. PubMed ID: 15007872
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Linezolid, an agent from a new class of antibiotics].
    Kuijper EJ; Schippers EF; Bernards AT
    Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.
    Mendes RE; Deshpande LM; Jones RN
    Drug Resist Updat; 2014 Apr; 17(1-2):1-12. PubMed ID: 24880801
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections.
    Fritsche TR; Kirby JT; Jones RN
    Diagn Microbiol Infect Dis; 2004 Jul; 49(3):201-9. PubMed ID: 15246511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.